{"title":"[Implementation of Clinical Research Aimed at Antimicrobial Stewardship].","authors":"Takehiro Yamada","doi":"10.1248/yakushi.24-00133","DOIUrl":null,"url":null,"abstract":"<p><p>The implementation of antimicrobial stewardship (AS) is an important issue that pharmacists should promote through cooperation with physicians and other medical professionals. A core strategy for AS is \"proactive intervention and feedback\" on antimicrobial prescriptions. We evaluated the AS program to optimize antimicrobial chemotherapy in patients with positive blood cultures. For patients with bacteremia, the rate of bacterial disappearance significantly improved in cases in which the feedback based on the antimicrobial susceptibility testing results by the AS team was accepted than in cases in which it was not. Additionally, we attempted to conduct therapeutic drug monitoring for important antimicrobial agents, such as colistin (anti-multidrug-resistant Pseudomonas aeruginosa agent), vancomycin, daptomycin (antibiotics for methicillin-resistant Staphylococcus aureus), and voriconazole (antifungal drug), to optimize dosage and administration for efficacy and safety. For daptomycin, we found a correlation between plasma through concentration and musculoskeletal toxicity in a clinical study. Moreover, direct toxicity to human skeletal cells was observed in an in vitro study using human myoblast cultures. Overall, the results of these studies indicate that further clinical research on AS may aid the improvement of patient efficacy and safety.</p>","PeriodicalId":23810,"journal":{"name":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","volume":"144 11","pages":"969-972"},"PeriodicalIF":0.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/yakushi.24-00133","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The implementation of antimicrobial stewardship (AS) is an important issue that pharmacists should promote through cooperation with physicians and other medical professionals. A core strategy for AS is "proactive intervention and feedback" on antimicrobial prescriptions. We evaluated the AS program to optimize antimicrobial chemotherapy in patients with positive blood cultures. For patients with bacteremia, the rate of bacterial disappearance significantly improved in cases in which the feedback based on the antimicrobial susceptibility testing results by the AS team was accepted than in cases in which it was not. Additionally, we attempted to conduct therapeutic drug monitoring for important antimicrobial agents, such as colistin (anti-multidrug-resistant Pseudomonas aeruginosa agent), vancomycin, daptomycin (antibiotics for methicillin-resistant Staphylococcus aureus), and voriconazole (antifungal drug), to optimize dosage and administration for efficacy and safety. For daptomycin, we found a correlation between plasma through concentration and musculoskeletal toxicity in a clinical study. Moreover, direct toxicity to human skeletal cells was observed in an in vitro study using human myoblast cultures. Overall, the results of these studies indicate that further clinical research on AS may aid the improvement of patient efficacy and safety.
实施抗菌药物管理(AS)是一个重要问题,药剂师应通过与医生和其他医疗专业人员合作来推动这一问题的解决。抗菌药物管理的核心策略是对抗菌药物处方进行 "主动干预和反馈"。我们对 AS 计划进行了评估,以优化血培养阳性患者的抗菌化疗。对于菌血症患者,接受 AS 团队根据抗菌药物药敏试验结果做出的反馈的病例,细菌消失率明显高于未接受反馈的病例。此外,我们还尝试对重要的抗菌药物进行治疗药物监测,如可乐定(抗多重耐药铜绿假单胞菌药物)、万古霉素、达托霉素(耐甲氧西林金黄色葡萄球菌抗生素)和伏立康唑(抗真菌药物),以优化剂量和用药,提高疗效和安全性。在一项临床研究中,我们发现达托霉素的血浆直通浓度与肌肉骨骼毒性之间存在相关性。此外,在一项利用人体成肌细胞进行的体外研究中,我们还观察到了该药物对人体骨骼细胞的直接毒性。总之,这些研究结果表明,对强直性脊柱炎的进一步临床研究可能有助于提高患者的疗效和安全性。